These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 28263462)

  • 1. Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.
    Khalsa J; Duffy LC; Riscuta G; Starke-Reed P; Hubbard VS
    Clin Pharmacol Drug Dev; 2017 Mar; 6(2):176-185. PubMed ID: 28263462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs.
    Noh K; Kang YR; Nepal MR; Shakya R; Kang MJ; Kang W; Lee S; Jeong HG; Jeong TC
    Arch Pharm Res; 2017 Dec; 40(12):1345-1355. PubMed ID: 29181640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.
    Li H; Jia W
    Clin Pharmacol Ther; 2013 Nov; 94(5):574-81. PubMed ID: 23933971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
    Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
    Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems biology perspective for studying the gut microbiota in human physiology and liver diseases.
    Altay O; Nielsen J; Uhlen M; Boren J; Mardinoglu A
    EBioMedicine; 2019 Nov; 49():364-373. PubMed ID: 31636011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug pharmacomicrobiomics and toxicomicrobiomics: from scattered reports to systematic studies of drug-microbiome interactions.
    Aziz RK; Hegazy SM; Yasser R; Rizkallah MR; ElRakaiby MT
    Expert Opin Drug Metab Toxicol; 2018 Oct; 14(10):1043-1055. PubMed ID: 30269615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
    Swanson HI
    Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of gut microbiota on drug metabolism and toxicity.
    Li H; He J; Jia W
    Expert Opin Drug Metab Toxicol; 2016; 12(1):31-40. PubMed ID: 26569070
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbiome interactions with drug metabolism, efficacy, and toxicity.
    Wilson ID; Nicholson JK
    Transl Res; 2017 Jan; 179():204-222. PubMed ID: 27591027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiota-drug interactions: Impact on metabolism and efficacy of therapeutics.
    Wilkinson EM; Ilhan ZE; Herbst-Kralovetz MM
    Maturitas; 2018 Jun; 112():53-63. PubMed ID: 29704918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota modulates drug pharmacokinetics.
    Zhang J; Zhang J; Wang R
    Drug Metab Rev; 2018 Aug; 50(3):357-368. PubMed ID: 30227749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbiota-derived uremic retention solutes: perpetrators of altered nonrenal drug clearance in kidney disease.
    Prokopienko AJ; Nolin TD
    Expert Rev Clin Pharmacol; 2018 Jan; 11(1):71-82. PubMed ID: 28905671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease.
    Paolella G; Mandato C; Pierri L; Poeta M; Di Stasi M; Vajro P
    World J Gastroenterol; 2014 Nov; 20(42):15518-31. PubMed ID: 25400436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human gut microbiota plays a role in the metabolism of drugs.
    Jourova L; Anzenbacher P; Anzenbacherova E
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):317-26. PubMed ID: 27485182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between drugs and the gut microbiome.
    Weersma RK; Zhernakova A; Fu J
    Gut; 2020 Aug; 69(8):1510-1519. PubMed ID: 32409589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Connecting the dots: Targeting the microbiome in drug toxicity.
    Luo Y; Zhou T
    Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gut microbiota as an "invisible organ" that modulates the function of drugs.
    Li X; Liu L; Cao Z; Li W; Li H; Lu C; Yang X; Liu Y
    Biomed Pharmacother; 2020 Jan; 121():109653. PubMed ID: 31810138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Microbiome and Its Potential for Pharmacology.
    Chavira A; Belda-Ferre P; Kosciolek T; Ali F; Dorrestein PC; Knight R
    Handb Exp Pharmacol; 2019; 260():301-326. PubMed ID: 31820171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The metabolic effect of gut microbiota on drugs.
    Xie Y; Hu F; Xiang D; Lu H; Li W; Zhao A; Huang L; Wang R
    Drug Metab Rev; 2020 Feb; 52(1):139-156. PubMed ID: 32116054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.